Alnylam Pharmaceuticals
ALNY
#622
Rank
โ‚น2.699 T
Marketcap
โ‚น20,931
Share price
2.75%
Change (1 day)
39.00%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company